Skip to content

A study to evaluate the management of blood pressure medications during major cancer surgeries and their impact on patient

Current practices of perioperative management strategy for patients on RAAS inhibitors undergoing major oncological surgery and perioperative outcomes - An observational study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/093381
Enrollment
500
Registered
2025-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients aged greater than 18years with American Society of Anesthesiologists grade 2 planned for major electiveoncologicalsurgery 2 Patients on RAAS inhibitors

Exclusion criteria

Exclusion criteria: 1 patients who are on multiple antihypertensives excluding ACEIs and ARBs 2 Emergency or unplanned surgeries 3 Day care or minor procedures 4 Patients with severe renal dysfunction 5 Patient with EF less than 35 percent 6 uncontrolled hypertension

Design outcomes

Primary

MeasureTime frame
To record perioperative management strategy for patients on RAAS inhibitors.Timepoint: On the day of surgery

Secondary

MeasureTime frame
To record the percentage of hypertensive patients receiving RAAS inhibitorsTimepoint: The no 1 secondary outcome will be recorded at the end of the study;To note incidence of intraoperative hypotensionTimepoint: will be assessed during the surgery;To note the requirement of vasoactive agentsTimepoint: will be assessed during the surgery;To evaluate for intraoperative and postoperative blood pressure changes if preoperatively bridging done with alternative antihypertensive agentTimepoint: will be assessed during the surgery;To note intraoperative blood loss and the amount of blood products transfusedTimepoint: The postoperative blood pressure changes will be assessed for a period of 24 hours at time points immediately after shifting to PACU then after 1 hour 4 hours 8 hours 12 hours and 24 hours;To note the episodes of hypotension /hypertension intraoperativelyTimepoint: will be assessed during the surgery

Countries

India

Contacts

Public ContactDr Vaidehi Mane

Tata Memorial Hospital

vijayappatil@yahoo.com9819883535

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026